How cytoplasmic DNA triggers inflammation in human cells

October 17, 2017, Ludwig Maximilian University of Munich
A cautionary tale
Human embryonic kidney cells stained for STING (magenta) and a lysosomal marker (green). In the non-stimulated state (left) the staining patterns are distinct, but after activation (right) STING is associated with the lysosomes, as indicated by the merging of the two fluorescent signals to give white. Credit: Veit Hornung

A team led by LMU's Veit Hornung has elucidated the mechanism by which human cells induce inflammation upon detection of cytoplasmic DNA. Notably, the signal network involved differs from that used in the same context in mice.

In , the hereditary material DNA is mostly confined to the nucleus, whereas the presence of DNA outside of the nucleus in the cytoplasm is a sign of danger to the cell. Cytoplasmic DNA may originate from bacterial or viral sources and thus indicate an infection, or it can be of endogenous origin and pinpoint tissue injury. Consequently, its recognition by the innate immune system induces broadly inflammatory countermeasures and defense mechanisms. Researchers at LMU's Gene Center, led by Professor Veit Hornung, have now elucidated the mechanisms that enable the innate immune system in to recognize such misplaced DNA and trigger an . Disproving the common assumption that innate recognition processes are evolutionarily largely conserved, in this particular case, Hornung and colleagues reveal that human differ fundamentally from mouse cells with regards to cytosolic DNA recognition. The new findings appear in the latest issue of the leading journal Cell.

The presence of free DNA in the cytoplasm activates two distinct defense measures. The first is an antiviral immune response, mediated by induction of the synthesis and secretion of immunostimulatory messenger molecules called interferons. The second is a classical inflammatory reaction, which elicits symptoms such as fever and localized swelling to allow recruitment of other immune cells to the site of emergency. A protein complex known as the inflammasome plays an important role in initiating the inflammation cascade by activating the protein interleukin 1, a central mediator of inflammation. "We wanted to know how the inflammasome recognizes foreign DNA and triggers inflammation in human cells," says Hornung. In previous studies, he and his collaborators had shown that in , a particular DNA-binding receptor is required to activate the inflammasome.

"Our latest study shows that in human myeloid cells, this receptor does not play a role in this process, because the functional module that recognizes foreign or misplaced DNA is hardwired in a different way," Hornung explains. In contrast to the mouse, the inflammasome of human myeloid cells is activated via the so-called cGAS-STING recognition mechanism, which is also responsible for triggering the to the presence of viral DNA. The researchers now report that activation of the cGAS-STING pathway results in programmed cell death independently of the antiviral reaction. "When the activation of the cGAS-STING pathway exceeds a certain threshold, the STING protein induces the disintegration of a class of intracellular membrane vesicles called lysosomes," said Moritz Gaidt, a post-doc in Hornung's group and first author of the new study. The resulting cell damage then activates the inflammasome to signal a local state of emergency by secreting interleukin 1. "By means of this inflammation reaction, the dying cell warns neighboring cells, which in turn recruit immune cells to the site of emergency," says Hornung.

The findings not only shed new light on the function of the human immune system, they also underline the fact that experiments carried out in model organisms do not always reliably translate into human biology. "In an exemplary fashion, our study demonstrates that it is worthwhile to study such signaling cascades directly in the human system," says Hornung.

Explore further: An alternative route to inflammation

More information: Moritz M. Gaidt et al. The DNA Inflammasome in Human Myeloid Cells Is Initiated by a STING-Cell Death Program Upstream of NLRP3, Cell (2017). DOI: 10.1016/j.cell.2017.09.039

Related Stories

An alternative route to inflammation

March 30, 2016
Using a combination of newly developed methods, researchers led by Ludwig-Maximilians-Universitaet (LMU) in Munich immunologist Veit Hornung have defined a previously unknown pathway that triggers inflammation.

The STING of death in T cells

September 5, 2017
The cells of the innate immune system use a signaling pathway comprising STING (Stimulator of interferon genes) to detect DNA from invading viruses and fight them. However, it is unknown if STING triggers the same or different ...

Cell senescence is regulated by innate DNA sensing

July 31, 2017
Cells in the body or in cultures eventually stop replicating. This phenomenon is called "senescence" and is triggered by shortening of telomeres, oxidative stress or genetic damage to the cells, either acute or simply due ...

Researchers identify tactic Dengue virus uses to delay triggering immune response

April 18, 2017
For the human body to mount an immune response to a viral infection, host cells must identify the viral invader and trigger a signaling pathway. This signal then prompts the immune system to attack and subdue the pathogen. ...

When DNA is out of place

June 4, 2013
When DNA that turns up in the wrong place in mammalian cells, the innate immune system reacts by secreting interferons. The structure and mode of action of the enzyme that mediates this response have now been elucidated.

Recommended for you

Novel genomic tools provide new insight into human immune system

January 19, 2018
When the body is under attack from pathogens, the immune system marshals a diverse collection of immune cells to work together in a tightly orchestrated process and defend the host against the intruders. For many decades, ...

Genomics reveals key macrophages' involvement in systemic sclerosis

January 18, 2018
A new international study has made an important discovery about the key role of macrophages, a type of immune cell, in systemic sclerosis (SSc), a chronic autoimmune disease which currently has no cure.

First vaccine developed against grass pollen allergy

January 18, 2018
Around 400 million people worldwide suffer in some form or other from a grass pollen allergy (rhinitis), with the usual symptoms of runny nose, cough and severe breathing problems. In collaboration with the Viennese firm ...

Researchers discover key driver of atopic dermatitis

January 17, 2018
Severe eczema, also known as atopic dermatitis, is a chronic inflammatory skin condition that is driven by an allergic reaction. In their latest study, researchers at La Jolla Institute reveal an important player that promotes ...

Who might benefit from immunotherapy? New study suggests possible marker

January 16, 2018
While immunotherapy has made a big impact on cancer treatment, the fact remains that only about a quarter of patients respond to these treatments.

Researchers identify new way to unmask melanoma cells to the immune system

January 16, 2018
system, which enables these deadly skin cancers to grow and spread.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.